Skip to main content

Peer Review reports

From: Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma

Original Submission
15 Apr 2023 Submitted Original manuscript
13 May 2023 Reviewed Reviewer Report
7 Jun 2023 Reviewed Reviewer Report
16 Jun 2023 Author responded Author comments - Yen-Hao Chen
Resubmission - Version 2
16 Jun 2023 Submitted Manuscript version 2
11 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
13 Aug 2023 Editorially accepted
29 Aug 2023 Article published 10.1186/s12885-023-11298-z

You can find further information about peer review here.

Back to article page